Change - Announcement of Cessation::Resignation of Chief Executive Officer / Managing Director - Dr Tan Pang Kee

Issuer & Securities

Issuer/ Manager
MATEX INTERNATIONAL LIMITED
Securities
MATEX INTERNATIONAL LIMITED - SG1P13916389 - M15
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
16-Sep-2025 09:52:37
Status
New
Announcement Sub Title
Resignation of Chief Executive Officer / Managing Director - Dr Tan Pang Kee
Announcement Reference
SG250916OTHRLEC8
Submitted By (Co./ Ind. Name)
James Kho Chung Wah
Designation
Independent Director
Description (Please provide a detailed description of the event in the box below)
Resignation of Dr Tan Pang Kee as the Chief Executive Officer / Managing Director of the Company with effect from 15 September 2025.

This announcement has been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Goh Mei Xian, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.

Additional Details

Name Of Person
Dr Tan Pang Kee
Age
78
Is effective date of cessation known?
Yes
If yes, please provide the date
15/09/2025
Detailed Reason (s) for cessation
The Company, Dr Tan Pang Kee, Mr Tan Guan Liang, Ms Lok Fong Meng, and other shareholders of the Company who have requisitioned shareholders meeting under Sections 176 and Section 177 of the Companies Act 1967 have entered into a settlement agreement. The Company is preparing for the settlement agreement announcement to be released separately soonest practicable.

Pursuant to the terms of the settlement agreement, Dr Tan Pang Kee ("Dr Tan") has tendered his resignation as Chief Executive Officer / Managing Director ("CEO/MD") of the Company with immediate effect. Dr Tan has also resigned from all other offices he holds in the Company and/or the Company's subsidiaries.

The Board would like to express its gratitude and appreciation towards Dr Tan for his valuable contributions to the Board during his tenure.

After having interviewed Dr Tan, and to the best of its knowledge, the Company's Sponsor is satisfied that, save as disclosed in this announcement, there are no other material reasons for the resignation of Dr Tan as CEO/MD of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Yes
If Yes, Please provide full details
Please refer to the announcements released by the Company on 3 September 2025 and 12 September 2025 in relation to the Company's responses to queries from the SGX RegCo for more information on the differences in opinion.
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Yes
If Yes, Please provide full details
Please refer to the announcement to be released separately by the Company at the soonest practicable time for information relating to Dr Tan's resignation as CEO/MD of the Company.
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
23/03/1990
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Executive Officer / Managing Director
Role and responsibilities
Responsible for overseeing the operations of the Company's business of trading.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Father to Mr Tan Guan Liang, Executive Director of the Company
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr Tan owns 87,972,630 (17.06%) ordinary shares in the paid-up share capital of the Company.
Other Directorships
Past (for the last 5 years)
Amly Chemicals Co., Ltd.
Matex Chemicals (Taixing) Co., Ltd.
Dedot Sdn. Bhd.
Dedot Pte. Ltd.
Matex Holdings (HK) Limited
Present
Matex International Limited
Shanghai Matex Chemicals Co., Ltd.
Unimatex Sdn Bhd.
Dedot Trading (Shanghai) Co., Ltd
Matex Holdings Pte. Ltd.
Matex Chemicals Technologies (Shanghai) Co., Ltd. Matexmega Pte. Ltd.